Tyme Technologies Inc, High Risk – High Reward | $TYME Like all Biotechnology companies, Tyme Technologies (NASDAQ: TYME) carries considerable risk as major moves can make or break a portfolio on the release of data at any moment. TYME is currently involves in a clinical program called SM-88, which is in development to target Cancer...